We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

284 hedge funds and large institutions have $609M invested in ARK Genomic Revolution ETF in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 104 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.9% more ownership

Funds ownership: 31.32% → 37.22% (+5.9%)

5% less funds holding

Funds holding: 298 → 284 (-14)

9% less capital invested

Capital invested by funds: $671M → $609M (-$61.7M)

25% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 36

38% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 104

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

59% less call options, than puts

Call options by funds: $49.5M | Put options by funds: $121M

Holders
284
Holders Change
-14
Holders Change %
-4.7%
% of All Funds
4.09%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
27
Increased
64
Reduced
104
Closed
36
Calls
$49.5M
Puts
$121M
Net Calls
-$71M
Net Calls Change
-$49.1M

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$35.3M
2
JP Morgan Chase
JP Morgan Chase
New York
+$24M
3
Wells Fargo
Wells Fargo
California
+$15.9M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.24M
5
Citigroup
Citigroup
New York
+$7.42M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$37.4M
2
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$9.15M
3
Goldman Sachs
Goldman Sachs
New York
-$8.92M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$7.29M
5
Two Sigma Investments
Two Sigma Investments
New York
-$6.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
251
Sanctuary Wealth Management
Idaho
$2.65K -$6.2K -206 -69%
HWA
252
HHM Wealth Advisors
Tennessee
$2.59K – – –
CIA
253
Cape Investment Advisory
Georgia
$2.59K -$1.5K -50 -36%
WWM
254
Wolff Wiese Magana
California
$2.44K – – –
CFO
255
CVA Family Office
Colorado
$2.1K – – –
LFG
256
Larson Financial Group
Missouri
$2.04K – – –
ST
257
Smithfield Trust
Pennsylvania
$2K – – –
TRCT
258
Tower Research Capital (TRC)
New York
$1.98K -$497K -16,527 -100%
KFS
259
Kelly Financial Services
Massachusetts
$1.9K – – –
SVCP
260
Silicon Valley Capital Partners
California
$1.78K – – –
RDFA
261
Ritter Daniher Financial Advisory
Ohio
$1.47K – – –
HCM
262
Hollencrest Capital Management
California
$1.44K – – –
RG
263
Retirement Group
California
$1.44K – – –
TAM
264
Tucker Asset Management
Colorado
$1.35K – – –
GFPC
265
Global Financial Private Client
Florida
$1.25K – – –
BBHC
266
Brown Brothers Harriman & Co
New York
$1.03K +$1.02K +34 +1,700%
BFO
267
Biltmore Family Office
North Carolina
$1.01K – – –
KFI
268
Key Financial Inc
Pennsylvania
$1.01K – – –
TFGT
269
TS Financial Group (TSFG)
Illinois
$1K -$9.23K -307 -94%
CMP
270
Coston McIsaac & Partners
Maine
$1K – – –
WWP
271
WR Wealth Planners
Missouri
$863 +$902 +30 New
WBC
272
West Branch Capital
Massachusetts
$816 – – –
CAM
273
Chesapeake Asset Management
New York
$723 -$4.21K -140 -85%
BC
274
Barrett & Company
Rhode Island
$719 – – –
MIM
275
Macroview Investment Management
Maryland
$662 -$1.2K -40 -63%
9 10
11
12 13

ARKG Hedge Fund Activity: Q1 2024 in Review

284 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2024, worth a combined $609M — down 9.2% from $671M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ARKG and 27 opened new positions — a net loss of 9 holders — while 104 trimmed existing stakes and 64 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $35.3M. The largest seller was Morgan Stanley, cutting an estimated $37.4M.

  • 284 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2024, down from 298 in Q4 2023.
  • Funds reported $609M of ARK Genomic Revolution ETF stock for Q1 2024, down 9.2% quarter-over-quarter.
  • 27 funds opened new ARK Genomic Revolution ETF positions in Q1 2024 and 36 closed out, a net change of -9 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2024 was BNP Paribas Financial Markets, an estimated $35.3M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2024 was Morgan Stanley, an estimated $37.4M sold.

Based on aggregated 13F filings for Q1 2024.